Antihypertensive Drug Market Report Forecast and Competitive Analysis to 2030 - Calcium Channel Blocker will Remain the Largest Segment During 2024-2030

News provided by

Dec 05, 2023, 10:30 ET

DUBLIN, Dec. 5, 2023 /PRNewswire/ -- The "Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.

The future of the global antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets. The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

Antihypertensive Drug Market Insights

Calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.
Within this market, hospital will remain the largest segment due to increase in number of hospitals worldwide.
North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Key Report Features

Market Size Estimates: Antihypertensive drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Antihypertensive drug market size by therapeutic class, distribution channel, and region in terms of value ($B).
Regional Analysis: Antihypertensive drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different therapeutic classes, distribution channels, and regions for the antihypertensive drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antihypertensive drug market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.

The study includes a forecast for the global antihypertensive drug by therapeutic class, distribution channel, and region.

Antihypertensive Drug Market by Therapeutic Class:

Diuretics
ACE Inhibitors
Calcium Channel Blockers
Vasodilators
Beta-Adrenergic Blockers
Others

Antihypertensive Drug Market by Distribution Channel:

Retail Pharmacy
Hospital Pharmacy
E-Commerce
Others

Antihypertensive Drug Market by Region:

North America
Europe
Asia Pacific
The Rest of the World

Antihypertensive Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antihypertensive drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.

Some of the antihypertensive drug companies profiled in this report include:

Lupin
Boehringer Ingelheim International
Sun PharmACEutical Industries
Astrazeneca
Novartis
SANOFI
Merck

Key Topics Covered:

1. Executive Summary

2. Global Antihypertensive Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Antihypertensive Drug Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Antihypertensive Drug Market by Therapeutic Class
3.3.1: Diuretics
3.3.2: ACE Inhibitors
3.3.3: Calcium Channel Blockers
3.3.4: Vasodilators
3.3.5: Beta-adrenergic Blockers
3.3.6: Others
3.4: Global Antihypertensive Drug Market by Distribution Channel
3.4.1: Retail Pharmacy
3.4.2: Hospital Pharmacy
3.4.3: E-commerce

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Antihypertensive Drug Market by Therapeutic Class
6.1.2: Growth Opportunities for the Global Antihypertensive Drug Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Antihypertensive Drug Market by Region
6.2: Emerging Trends in the Global Antihypertensive Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Antihypertensive Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antihypertensive Drug Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

For more information about this report visit https://www.researchandmarkets.com/r/ogux0g

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets